{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:53:18Z","timestamp":1794703998157,"version":"4.9.1"},"reference-count":68,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Postnatal thymic involution occurs progressively throughout the first 3 decades of life. It predominantly affects T-cell receptor (TCR) \u03b1\u03b2-lineage precursors, with a consequent proportional increase in multipotent thymic precursors. We show that T-acute lymphoblastic leukemias (T-ALLs) demonstrate a similar shift with age from predominantly TCR expressing to an immature (IM0\/\u03b4\/\u03b3) stage of maturation arrest. Half demonstrate HOX11, HOX11L2, SIL-TAL1, or CALM-AF10 deregulation, with each being associated with a specific, age-independent stage of maturation arrest. HOX11 and SIL-TAL represent \u03b1\u03b2-lineage oncogenes, whereas HOX11L2 expression identifies an intermediate \u03b1\u03b2\/\u03b3\u03b4-lineage stage of maturation arrest. In keeping with preferential \u03b1\u03b2-lineage involution, the incidence of SIL-TAL1 and HOX11L2 deregulation decreased with age. In contrast, HOX11 deregulation became more frequent, suggesting longer latency. TAL1\/LMO1 deregulation is more frequent in \u03b1\u03b2-lineage T-ALL, when it is predominantly due to SIL-TAL1 rearrangements in children but to currently unknown mechanisms in adolescents and adults. LMO2 was more frequently coexpressed with LYL1, predominantly in IM0\/\u03b4\/\u03b3 adult cases, than with TAL1. These age-related changes in phenotype and oncogenic pathways probably reflect progressive changes in the thymic population at risk of malignant transformation.<\/jats:p>","DOI":"10.1182\/blood-2003-11-3944","type":"journal-article","created":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T00:13:07Z","timestamp":1081210387000},"page":"4173-4180","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":108,"title":["Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy"],"prefix":"10.1182","volume":"104","author":[{"given":"Vahid","family":"Asnafi","sequence":"first","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheira","family":"Beldjord","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Libura","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Villarese","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Millien","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ballerini","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilienne","family":"Kuhlein","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lafage-Pochitaloff","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bernard","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[{"name":"From the Necker-Enfants-Malades and Trousseau, Assistance Publique-Hopitaux de Paris (AP-HP), INSERM EMIU210 and Universite\u0301 Paris V, Ho\u0302pital Purpan, Toulouse, France; and Institut Paoli Calmettes, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218521727900_REF1","doi-asserted-by":"crossref","unstructured":"Berzins SP, Boyd RL, Miller JF. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med. 1998;187: 1839-1848.","DOI":"10.1084\/jem.187.11.1839"},{"key":"2020021218521727900_REF2","doi-asserted-by":"crossref","unstructured":"Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol. 2000;20: 250-256.","DOI":"10.1023\/A:1006611518223"},{"key":"2020021218521727900_REF3","doi-asserted-by":"crossref","unstructured":"Aspinall R, Andrew D. Age-associated thymic atrophy is not associated with a deficiency in the CD44(+)CD25(-)CD3(-)CD4(-)CD8(-) thymocyte population. Cell Immunol. 2001;212: 150-157.","DOI":"10.1006\/cimm.2001.1848"},{"key":"2020021218521727900_REF4","doi-asserted-by":"crossref","unstructured":"Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol. 1993;150: 4244-4252.","DOI":"10.4049\/jimmunol.150.10.4244"},{"key":"2020021218521727900_REF5","doi-asserted-by":"crossref","unstructured":"Shortman K, Wu L. Early T lymphocyte progenitors. Annu Rev Immunol. 1996;14: 29-47.","DOI":"10.1146\/annurev.immunol.14.1.29"},{"key":"2020021218521727900_REF6","doi-asserted-by":"crossref","unstructured":"Kampinga J, Schuurman HJ, Pol GH, et al. Vascular thymus transplantation in rats. Technique, morphology, and function. Transplantation. 1990; 50: 669-678.","DOI":"10.1097\/00007890-199010000-00028"},{"key":"2020021218521727900_REF7","doi-asserted-by":"crossref","unstructured":"Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165: 75-86.","DOI":"10.1111\/j.1600-065X.1998.tb01231.x"},{"key":"2020021218521727900_REF8","doi-asserted-by":"crossref","unstructured":"Breit TM, Wolvers-Tettero IL, van Dongen JJ. Phenotypic and genotypic characteristics of human early T-cell differentiation: the T-cell acute lymphoblastic leukaemia model. Res Immunol. 1994;145: 139-143; discussion 155-138.","DOI":"10.1016\/S0923-2494(94)80027-8"},{"key":"2020021218521727900_REF9","doi-asserted-by":"crossref","unstructured":"Boucheix C, David B, Sebban C, et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood. 1994;84: 1603-1612.","DOI":"10.1182\/blood.V84.5.1603.bloodjournal8451603"},{"key":"2020021218521727900_REF10","doi-asserted-by":"crossref","unstructured":"Gomez E, San Miguel JF, Gonzalez M, et al. Heterogeneity of T cell lymphoblastic leukaemias. J Clin Pathol. 1991;44: 628-631.","DOI":"10.1136\/jcp.44.8.628"},{"key":"2020021218521727900_REF11","doi-asserted-by":"crossref","unstructured":"Dube ID, Kamel-Reid S, Yuan CC, et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood. 1991;78: 2996-3003.","DOI":"10.1182\/blood.V78.11.2996.2996"},{"key":"2020021218521727900_REF12","doi-asserted-by":"crossref","unstructured":"Kennedy MA, Gonzalez-Sarmiento R, Kees UR, et al. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci U S A. 1991;88: 8900-8904.","DOI":"10.1073\/pnas.88.20.8900"},{"key":"2020021218521727900_REF13","doi-asserted-by":"crossref","unstructured":"Lu M, Gong ZY, Shen WF, Ho AD. The tcl-3 protooncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein. EMBO J. 1991;10: 2905-2910.","DOI":"10.1002\/j.1460-2075.1991.tb07840.x"},{"key":"2020021218521727900_REF14","doi-asserted-by":"crossref","unstructured":"McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ. The t(11;14)(p15; q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol. 1989;9: 2124-2132.","DOI":"10.1128\/MCB.9.5.2124"},{"key":"2020021218521727900_REF15","unstructured":"Royer-Pokora B, Loos U, Ludwig WD. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene. 1991;6: 1887-1893."},{"key":"2020021218521727900_REF16","doi-asserted-by":"crossref","unstructured":"Mellentin JD, Smith SD, Cleary ML. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell. 1989;58: 77-83.","DOI":"10.1016\/0092-8674(89)90404-2"},{"key":"2020021218521727900_REF17","doi-asserted-by":"crossref","unstructured":"Wang J, Jani-Sait SN, Escalon EA, et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A. 2000;97: 3497-3502.","DOI":"10.1073\/pnas.97.7.3497"},{"key":"2020021218521727900_REF18","doi-asserted-by":"crossref","unstructured":"Xia Y, Brown L, Yang CY, et al. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci U S A. 1991;88: 11416-11420.","DOI":"10.1073\/pnas.88.24.11416"},{"key":"2020021218521727900_REF19","doi-asserted-by":"crossref","unstructured":"Fitzgerald TJ, Neale GA, Raimondi SC, Goorha RM. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a recip-rocal chromosomal translocation: t(1;7)(p32;q35). Blood. 1991;78: 2686-2695.","DOI":"10.1182\/blood.V78.10.2686.2686"},{"key":"2020021218521727900_REF20","doi-asserted-by":"crossref","unstructured":"Brown L, Cheng JT, Chen Q, et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990;9: 3343-3351.","DOI":"10.1002\/j.1460-2075.1990.tb07535.x"},{"key":"2020021218521727900_REF21","unstructured":"Baer R. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol. 1993;4: 341-347."},{"key":"2020021218521727900_REF22","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1: 75-87.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"2020021218521727900_REF23","doi-asserted-by":"crossref","unstructured":"Cayuela JM, Hebert J, Sigaux F. Homozygous MTS1 (p16INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood. 1995;85: 854.","DOI":"10.1182\/blood.V85.3.854a.bloodjournal853854a"},{"key":"2020021218521727900_REF24","doi-asserted-by":"crossref","unstructured":"Kawamura M, Ohnishi H, Guo SX, et al. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res. 1999;23: 115-126.","DOI":"10.1016\/S0145-2126(98)00146-5"},{"key":"2020021218521727900_REF25","doi-asserted-by":"crossref","unstructured":"Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig WD, van Wering ER, van Dongen JJ. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha\/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med. 1993;177: 965-977.","DOI":"10.1084\/jem.177.4.965"},{"key":"2020021218521727900_REF26","unstructured":"Bernard O, Lecointe N, Jonveaux P, et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5\u2032 part of the tal-1 gene. Oncogene. 1991;6: 1477-1488."},{"key":"2020021218521727900_REF27","doi-asserted-by":"crossref","unstructured":"Macintyre EA, Smit L, Ritz J, Kirsch IR, Strominger JL. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage. Blood. 1992;80: 1511-1520","DOI":"10.1182\/blood.V80.6.1511.1511"},{"key":"2020021218521727900_REF28","unstructured":"Janssen JW, Ludwig WD, Sterry W, Bartram CR. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia. 1993;7: 1204-1210."},{"key":"2020021218521727900_REF29","doi-asserted-by":"crossref","unstructured":"Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 2001;15: 1495-1504.","DOI":"10.1038\/sj.leu.2402249"},{"key":"2020021218521727900_REF30","doi-asserted-by":"crossref","unstructured":"Ballerini P, Blaise A, Busson-Le Coniat M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100: 991-997.","DOI":"10.1182\/blood-2001-11-0093"},{"key":"2020021218521727900_REF31","doi-asserted-by":"crossref","unstructured":"Berger R, Dastugue N, Busson M, et al. t(5;14)\/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia. 2003;17: 1851-1857.","DOI":"10.1038\/sj.leu.2403061"},{"key":"2020021218521727900_REF32","doi-asserted-by":"crossref","unstructured":"Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science. 1991;253: 79-82.","DOI":"10.1126\/science.1676542"},{"key":"2020021218521727900_REF33","unstructured":"Salvati PD, Ranford PR, Ford J, Kees UR. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. Oncogene. 1995;11: 1333-1338."},{"key":"2020021218521727900_REF34","unstructured":"Ferrando A, Neuberg D, Dodge RK, et al. Adult T-cell ALL patients whose lymphoblasts express the HOX11 oncogene have an excellent prognosis when treated with chemotherapy and are not candidates for allogeneic bone marrow Transplantation in first remission [abstract]. Blood. 2002;10: 154a."},{"key":"2020021218521727900_REF35","doi-asserted-by":"crossref","unstructured":"Groupe Franc\u0327ais de Cytoge\u0301ne\u0301tique He\u0301matologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood. 1996;87: 3135-3142.","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135"},{"key":"2020021218521727900_REF36","doi-asserted-by":"crossref","unstructured":"Cave H, Suciu S, Preudhomme C, et al. Clinical significance of HOX11L2 expression linked to t(5; 14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood. 2004;103: 442-450.","DOI":"10.1182\/blood-2003-05-1495"},{"key":"2020021218521727900_REF37","unstructured":"Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9: 1783-1786."},{"key":"2020021218521727900_REF38","doi-asserted-by":"crossref","unstructured":"Asnafi V, Beldjord K, Boulanger E, et al. Analysis of TCR, pT{alpha} and RAG-1 in T acute lymphoblastic leukemias improves understanding of early human T lymphoid lineage commitment. Blood. 2002;101: 2693-2703.","DOI":"10.1182\/blood-2002-08-2438"},{"key":"2020021218521727900_REF39","doi-asserted-by":"crossref","unstructured":"Asnafi V, Radford-Weiss I, Dastugue N, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR(gamma)(delta) lineage. Blood. 2003;102: 1000-1006.","DOI":"10.1182\/blood-2002-09-2913"},{"key":"2020021218521727900_REF40","doi-asserted-by":"crossref","unstructured":"Miyamoto A, Cui X, Naumovski L, Cleary ML. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol Cell Biol. 1996;16: 2394-2401.","DOI":"10.1128\/MCB.16.5.2394"},{"key":"2020021218521727900_REF41","doi-asserted-by":"crossref","unstructured":"Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY. Expression of TAL-1 proteins in human tissues. Blood. 1995;85: 675-684.","DOI":"10.1182\/blood.V85.3.675.bloodjournal853675"},{"key":"2020021218521727900_REF42","doi-asserted-by":"crossref","unstructured":"Rabbitts TH. Chromosomal translocation master genes, mouse models and experimental therapeutics. Oncogene. 2001;20: 5763-5777.","DOI":"10.1038\/sj.onc.1204597"},{"key":"2020021218521727900_REF43","doi-asserted-by":"crossref","unstructured":"Chervinsky DS, Zhao XF, Lam DH, Ellsworth M, Gross KW, Aplan PD. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol. 1999;19: 5025-5035.","DOI":"10.1128\/MCB.19.7.5025"},{"key":"2020021218521727900_REF44","doi-asserted-by":"crossref","unstructured":"Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat Immunol. 2000;1: 138-144.","DOI":"10.1038\/77819"},{"key":"2020021218521727900_REF45","doi-asserted-by":"crossref","unstructured":"Brumpt C, Delabesse E, Beldjord K, et al. The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood. 2000;96: 2254-2261.","DOI":"10.1182\/blood.V96.6.2254"},{"key":"2020021218521727900_REF46","doi-asserted-by":"crossref","unstructured":"Delabesse E, Burtin ML, Millien C, et al. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia. 2000;14: 1143-1152.","DOI":"10.1038\/sj.leu.2401750"},{"key":"2020021218521727900_REF47","doi-asserted-by":"crossref","unstructured":"Beillard E, Pallisgaard N, van der Velden VHJ, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014A Europe Against Cancer Programme. Leukemia. 2003;17: 2474-2486.","DOI":"10.1038\/sj.leu.2403136"},{"key":"2020021218521727900_REF48","doi-asserted-by":"crossref","unstructured":"Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol. 1997;158: 3037-3045.","DOI":"10.4049\/jimmunol.158.7.3037"},{"key":"2020021218521727900_REF49","doi-asserted-by":"crossref","unstructured":"Capone M, Hockett RD Jr, Zlotnik A. Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) pro-T thymocytes. Proc Natl Acad Sci U S A. 1998;95: 12522-12527.","DOI":"10.1073\/pnas.95.21.12522"},{"key":"2020021218521727900_REF50","doi-asserted-by":"crossref","unstructured":"Fehling HJ, Krotkova A, Saint-Ruf C, von Boehmer H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature. 1995;375: 795-798.","DOI":"10.1038\/375795a0"},{"key":"2020021218521727900_REF51","doi-asserted-by":"crossref","unstructured":"MacDonald HR, Radtke F, Wilson A. T cell fate specification and alphabeta\/gammadelta lineage commitment. Curr Opin Immunol. 2001;13: 219-224.","DOI":"10.1016\/S0952-7915(00)00207-7"},{"key":"2020021218521727900_REF52","doi-asserted-by":"crossref","unstructured":"Gounari F, Aifantis I, Martin C, et al. Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat Immunol. 2002;3: 489-496.","DOI":"10.1038\/ni778"},{"key":"2020021218521727900_REF53","doi-asserted-by":"crossref","unstructured":"Hansen-Hagge TE, Schafer M, Kiyoi H, et al. Disruption of the RanBP17\/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia. 2002;16: 2205-2212.","DOI":"10.1038\/sj.leu.2402671"},{"key":"2020021218521727900_REF54","doi-asserted-by":"crossref","unstructured":"Wakabayashi Y, Watanabe H, Inoue J, et al. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol. 2003; 4: 533-539.","DOI":"10.1038\/ni927"},{"key":"2020021218521727900_REF55","doi-asserted-by":"crossref","unstructured":"Leroy-Viard K, Vinit MA, Lecointe N, et al. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J. 1995;14: 2341-2349.","DOI":"10.1002\/j.1460-2075.1995.tb07229.x"},{"key":"2020021218521727900_REF56","doi-asserted-by":"crossref","unstructured":"Delabesse E, Bernard M, Landman-Parker J, et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br J Haematol. 1997;99: 901-907.","DOI":"10.1046\/j.1365-2141.1997.4833286.x"},{"key":"2020021218521727900_REF57","doi-asserted-by":"crossref","unstructured":"Aplan PD, Jones CA, Chervinsky DS, et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 1997;16: 2408-2419.","DOI":"10.1093\/emboj\/16.9.2408"},{"key":"2020021218521727900_REF58","doi-asserted-by":"crossref","unstructured":"Larson RC, Lavenir I, Larson TA, et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 1996;15: 1021-1027.","DOI":"10.1002\/j.1460-2075.1996.tb00439.x"},{"key":"2020021218521727900_REF59","doi-asserted-by":"crossref","unstructured":"Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu Rev Immunol. 2002;20: 301-322.","DOI":"10.1146\/annurev.immunol.20.092501.162048"},{"key":"2020021218521727900_REF60","doi-asserted-by":"crossref","unstructured":"Bandeira A, Mota-Santos T, Itohara S, et al. Localization of gamma\/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med. 1990;172: 239-244.","DOI":"10.1084\/jem.172.1.239"},{"key":"2020021218521727900_REF61","doi-asserted-by":"crossref","unstructured":"Guy-Grand D, Cerf-Bensussan N, Malissen B, Malassis-Seris M, Briottet C, Vassalli P. Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med. 1991;173: 471-481.","DOI":"10.1084\/jem.173.2.471"},{"key":"2020021218521727900_REF62","doi-asserted-by":"crossref","unstructured":"Salvati PD, Watt PM, Thomas WR, Kees UR. Molecular characterization of a complex chromosomal translocation breakpoint t(10;14) including the HOX11 oncogene locus. Leukemia. 1999;13: 975-979.","DOI":"10.1038\/sj.leu.2401421"},{"key":"2020021218521727900_REF63","unstructured":"Asnafi V, Thomas X, Villarese P, et al. Hox11 and Hox11L2 quantification in adult T-ALL [abstract]. Blood. 2002;100: 154a."},{"key":"2020021218521727900_REF64","doi-asserted-by":"crossref","unstructured":"Dear TN, Colledge WH, Carlton MB, et al. The Hox11 gene is essential for cell survival during spleen development. Development. 1995;121: 2909-2915.","DOI":"10.1242\/dev.121.9.2909"},{"key":"2020021218521727900_REF65","doi-asserted-by":"crossref","unstructured":"Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002;100: 3828-3831.","DOI":"10.1182\/blood-2002-03-0937"},{"key":"2020021218521727900_REF66","doi-asserted-by":"crossref","unstructured":"Greene WK, Ford J, Dixon D, et al. Enforced expression of HOX11 is associated with an immature phenotype in J2E erythroid cells. Br J Haematol. 2002;118: 909-917.","DOI":"10.1046\/j.1365-2141.2002.03704.x"},{"key":"2020021218521727900_REF67","unstructured":"Hawley RG, Fong AZ, Lu M, Hawley TS. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene. 1994;9: 1-12."},{"key":"2020021218521727900_REF68","unstructured":"Hawley RG, Fong AZ, Reis MD, Zhang N, Lu M, Hawley TS. Transforming function of the HOX11\/TCL3 homeobox gene. Cancer Res. 1997;57: 337-345."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4173\/1704747\/zh802404004173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4173\/1704747\/zh802404004173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T06:44:46Z","timestamp":1682664286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/13\/4173\/19005\/Agerelated-phenotypic-and-oncogenic-differences-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,15]]},"references-count":68,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-11-3944","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,15]]}}}